Vildato 50 Tablets contain Vildagliptin 50 mg, a DPP-4 inhibitor used for the management of Type 2 Diabetes. It improves insulin secretion, reduces glucagon levels, and provides effective blood glucose control with a low risk of hypoglycemia.
Vildagliptin inhibits the dipeptidyl peptidase-4 (DPP-4) enzyme, leading to increased levels of incretin hormones such as GLP-1 and GIP. These hormones enhance glucose-dependent insulin secretion and suppress glucagon release, resulting in improved blood glucose control without significant risk of hypoglycemia.
Key Benefits
Effective control of blood glucose levels
Improves postprandial glucose regulation
Low risk of hypoglycemia
Helps reduce HbA1c levels
Well tolerated in most patients
Can be used as monotherapy or in combination
Indications
Type 2 Diabetes Mellitus
As monotherapy or in combination with other anti-diabetic agents
Dosage & Administration
To be taken as directed by the physician
Commonly administered once or twice daily, with or without food
Precautions
Monitor liver function periodically
Use cautiously in patients with renal or hepatic impairment
Regular monitoring of blood glucose is recommended
Contraindications
Hypersensitivity to Vildagliptin or any component
Severe hepatic impairment
Storage
Store in a cool and dry place below 25°C
Protect from light and moisture
Keep out of reach of children
Packaging
10 x 15 Tablets
Reviews
There are no reviews yet.
Be the first to review “Vildato 50 Tablets”Cancel Reply
Reviews
There are no reviews yet.